A biodegradable two-dimensional (2D) delivery platform based on loading black phosphorus nanosheets (BPs) with Cas9 ribonucleoprotein engineered with three nuclear localization signals (NLSs) at C terminus (Cas9N3) is successfully established. The Cas9N3-BPs enter cells effectively via membrane penetration and endocytosis pathways, followed by a BPs biodegradation-associated endosomal escape and cytosolic releases of the loaded Cas9N3 complexes. The Cas9N3-BPs thus provide efficient genome editing and gene silencing in vitro and in vivo at a relatively low dose as compared with other nanoparticle-based delivery platforms. This biodegradable 2D delivery platform offers a versatile cytosolic delivery approach for CRISPR/Cas9 ribonucleoprotein...
Delivery is a key challenge in novel protein therapeutic development. Even though numerous proteins ...
Abstract(#br)CRISPR/Cas9 (clustered regularly interspaced short palindromic repeat/clustered regular...
Ex vivo gene editing of CD34+ hematopoietic stem and progenitor cells (HSPCs) offers great opportuni...
In this study, direct and effective intracellular delivery of CRISPR/Cas9 plasmids for homology-dire...
CRISPR/Cas9 has become an attractive tool for performing genomic editing due to its versatility and ...
© 2022 Elsevier B.V.Programmable endonucleases such as CRISPR/Cas9 system emerge as a promising tool...
A transient cytosolic delivery system for accurate Cas9 ribonucleoprotein is a key factor for target...
Effective and safe delivery of the CRISPR/Cas9 gene-editing elements remains a challenge. Here we re...
CRISPR-Cas9 represents a promising technology for genome editing, yet means of safe and efficient de...
CRISPR/Cas9 is a genome editing technology that uses an RNA-guided programmable nuclease, Cas9, for ...
Appropriate tuning of robust artificial coatings can not only enhance intracellular delivery but als...
Ribonucleoprotein (RNP) based CRISPR/Cas9 gene-editing system shows great potential in biomedical ap...
Abstract The clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR‐related p...
The emergence of the CRISPR–Cas9 gene editing system has generated considerable hope and excitement ...
Genetic editing technologies have emerged as a potential therapeutic tool in various biomedical fiel...
Delivery is a key challenge in novel protein therapeutic development. Even though numerous proteins ...
Abstract(#br)CRISPR/Cas9 (clustered regularly interspaced short palindromic repeat/clustered regular...
Ex vivo gene editing of CD34+ hematopoietic stem and progenitor cells (HSPCs) offers great opportuni...
In this study, direct and effective intracellular delivery of CRISPR/Cas9 plasmids for homology-dire...
CRISPR/Cas9 has become an attractive tool for performing genomic editing due to its versatility and ...
© 2022 Elsevier B.V.Programmable endonucleases such as CRISPR/Cas9 system emerge as a promising tool...
A transient cytosolic delivery system for accurate Cas9 ribonucleoprotein is a key factor for target...
Effective and safe delivery of the CRISPR/Cas9 gene-editing elements remains a challenge. Here we re...
CRISPR-Cas9 represents a promising technology for genome editing, yet means of safe and efficient de...
CRISPR/Cas9 is a genome editing technology that uses an RNA-guided programmable nuclease, Cas9, for ...
Appropriate tuning of robust artificial coatings can not only enhance intracellular delivery but als...
Ribonucleoprotein (RNP) based CRISPR/Cas9 gene-editing system shows great potential in biomedical ap...
Abstract The clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR‐related p...
The emergence of the CRISPR–Cas9 gene editing system has generated considerable hope and excitement ...
Genetic editing technologies have emerged as a potential therapeutic tool in various biomedical fiel...
Delivery is a key challenge in novel protein therapeutic development. Even though numerous proteins ...
Abstract(#br)CRISPR/Cas9 (clustered regularly interspaced short palindromic repeat/clustered regular...
Ex vivo gene editing of CD34+ hematopoietic stem and progenitor cells (HSPCs) offers great opportuni...